Last updated on December 2018

Efficacy and Safety of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU)

Brief description of study

The purpose this study is to evaluate the efficacy, safety, and pharmacokinetics of GDC-0853 compared with placebo in participants with Chronic Spontaneous Urticaria (CSU) refractory to anti-histamines.

Clinical Study Identifier: NCT03137069

Contact Investigators or Research Sites near you

Start Over

Cheema Research, Inc

Mississauga, ON Canada
  Connect »

Syneos Health

Brossard, QC Canada
  Connect »

San Tan Allergy & Asthma

Gilbert, AZ United States
  Connect »

Kern Allergy Med Clinic, Inc.

Bakersfield, CA United States
  Connect »

Integrated Research Group Inc

Riverside, CA United States
  Connect »

TTS Research

Boerne, TX United States
  Connect »

Allergy & Asthma Consultants

Redwood City, CA United States
  Connect »

Lynderm Research

Markham, ON Canada
  Connect »

York Dermatology Center

Richmond Hill, ON Canada
  Connect »

Southern California Research Center

Mission Viejo, CA United States
  Connect »

Renstar Medical Research

Ocala, FL United States
  Connect »

Dr. Isabelle Delorme, Inc

Drummondville, QC Canada
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.